Filing Details

Accession Number:
0001104659-24-115837
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-08 15:59:32
Reporting Period:
2023-01-03
Accepted Time:
2024-11-08 15:59:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1875558 Nuvectis Pharma Inc. NVCT Pharmaceutical Preparations (2834) 862405608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1896079 J. Michael Carson C/O Nuvectis Pharma, Inc.
1 Bridge Plaza, Suite 275
Fort Lee NJ 07024
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-03 28,806 $0.00 56,106 No 4 A Direct
Common Stock Acquisiton 2024-01-04 34,567 $0.00 90,673 No 4 A Direct
Common Stock Disposition 2024-11-07 2,755 $8.16 87,918 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. The 28,806 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
  2. Includes shares of restricted common stock, which vest over various time periods.
  3. The 34,567 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
  4. In connection with the vesting of 9,100 shares, 2,755 shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Carson's tax withholding obligations. Mr. Carson had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.